pathobiology & treatment of t-pll
Published 2 years ago • 1.2K plays • Length 3:56Download video MP4
Download video MP3
Similar videos
-
2:58
itacitinib plus alemtuzumab for patients with t-pll
-
6:32
pathobiology and clinical management of t-cell lymphoma
-
1:26
ruxolitinib plus venetoclax for t-pll: rationale and findings
-
1:23
the current treatment landscape for patients with t-cell prolymphocytic leukemia
-
1:44
treatment options for patients with early t-cell precursor all
-
4:26
phase ib study of orca-t in patients with advanced hematologic malignancies
-
8:57
outcomes of sct in t-all and t-lbl
-
1:25
the diagnosis of early t-cell precursor (etp) all
-
51:24
‘standing on the shoulders of the giants’ with prof. giampaolo merlini
-
10:19
early t-cell precursor lymphoblastic leukemia (etp-all)
-
26:24
prolymphocytic leukemia peripheral blood smear with toula
-
1:31
pegenzileukin for t-cell dysfunction
-
1:13
the importance of improving the management of cardiotoxicity when treating cll
-
0:59
the treatment of patients with t(11;14) myeloma
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
3:05
the benefits of pet in the prognosis and treatment of hl
-
2:24
the treatment and management of ptld
-
1:17
the use of pacritinib in thrombocytopenic patients with myelofibrosis undergoing allosct
-
1:56
strategies for the management of ebv-ptld
-
2:47
targeting pathogenic pathways in lymphoproliferative diseases
-
1:34
the role of the immune microenvironment in ptld
-
0:50
management of variant acute promyelocytic leukemia